ERIS Lifescience

{
  "main_header": {
    "sid": 1002771,
    "name": "ERIS Lifescience",
    "stock_name": "ERIS Lifescience",
    "full_name": "ERIS Lifesciences Ltd",
    "name_url": "stocks-analysis/eris-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,274.55",
    "chg": 4.7,
    "chgp": "0.37%",
    "dir": 1,
    "prev_price": "1,269.85",
    "mcapval": "17,661.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 540596,
    "symbol": "ERIS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE406M01024",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "00:54 AM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": "48.24 k",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/eris-lifescience-1002771-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ERIS Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eris-lifesciences-ltd-is-rated-sell-4197837",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ERISLifescience_mojoScore_4197837.png",
        "date": "2026-09-19 10:10:47",
        "description": "ERIS Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 26 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 September 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "ERIS Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eris-lifesciences-ltd-is-rated-sell-by-marketsmojo-4186267",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ERISLifescience_mojoScore_4186267.png",
        "date": "2026-09-08 10:11:17",
        "description": "ERIS Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 26 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 September 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "ERIS Lifesciences Declines 0.63%: Technical Weakness and Growth Concerns Weigh",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eris-lifesciences-declines-063-technical-weakness-and-growth-concerns-weigh-4174330",
        "imagepath": "",
        "date": "2026-08-29 13:02:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Aug 24:</strong> Stock edges up slightly to ₹1,326.20 despite Sensex decline</p>\n                    <p><strong>Aug 25:</strong> Stock falls 1.26% amid Sensex gains</p>\n                    <p><strong>Aug 27:</strong> Downgrade to Sell rating announced with bearish technical signals</p>\n                    <p><strong>Aug 28:</strong> Stock recovers modestly to close at ₹1,317.10</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,325.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs...."
      },
      {
        "title": "ERIS Lifesciences Downgraded to Sell Amid Technical Weakness and Growth Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eris-lifesciences-downgraded-to-sell-amid-technical-weakness-and-growth-concerns-4171019",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ERISLifescience_mojoScore_4171019.png",
        "date": "2026-08-27 08:21:53",
        "description": "ERIS Lifesciences Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 26 Aug 2026, reflecting a deterioration in its technical outlook and continued underperformance relative to the broader market. Despite some positive financial metrics, the stock’s bearish technical signals and weak price returns over the past year have prompted a reassessment of its investment appeal."
      },
      {
        "title": "ERIS Lifesciences Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eris-lifesciences-ltd-faces-bearish-momentum-amid-technical-downgrade-4170911",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ERISLifescience_technicaldot_4170911.png",
        "date": "2026-08-27 08:04:09",
        "description": "ERIS Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, prompting a downgrade from Hold to Sell by MarketsMOJO as of 26 August 2026. The stock’s price action and technical indicators reveal a growing bearish sentiment, reflecting challenges in sustaining upward momentum amid broader market pressures."
      },
      {
        "title": "ERIS Lifesciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eris-lifesciences-ltd-is-rated-hold-by-marketsmojo-4156253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ERISLifescience_mojoScore_4156253.png",
        "date": "2026-08-16 10:10:41",
        "description": "ERIS Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 August 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "ERIS Lifesciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eris-lifesciences-ltd-is-rated-hold-by-marketsmojo-4137724",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ERISLifescience_mojoScore_4137724.png",
        "date": "2026-08-05 10:11:29",
        "description": "ERIS Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "ERIS Lifesciences Declines 3.30% Amid Valuation Reset and Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eris-lifesciences-declines-330-amid-valuation-reset-and-margin-pressures-4131505",
        "imagepath": "",
        "date": "2026-08-01 13:05:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock opens at Rs.1,399.95, marginal gain despite Sensex rally</p>\n                    <p><strong>29 Jul:</strong> Q1 FY27 results announced with strong sales growth but margin pressure</p>\n                    <p><strong>31 Jul:</strong> Valuation shifts to fair; stock closes lower at Rs.1,352.75</p>\n                    <p><strong>31 Jul:</strong> Week closes with a 3.30% decline in stock price versus Sensex +2.39%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,398.90</div></div>\n                    <div class=\"stat-item\"><div class=\"..."
      },
      {
        "title": "ERIS Lifesciences Ltd Valuation Shifts to Fair Amidst Sector Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eris-lifesciences-ltd-valuation-shifts-to-fair-amidst-sector-volatility-4129461",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ERISLifescience_valuationdot_4129461.png",
        "date": "2026-07-31 08:00:52",
        "description": "ERIS Lifesciences Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling a more attractive entry point for investors. Despite a recent 3.62% decline in its share price to ₹1,375.60, the pharmaceutical and biotechnology company’s improved price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to peers and historical averages suggest a recalibration of market expectations amid broader sector dynamics."
      }
    ],
    "total": 352,
    "sid": "1002771",
    "stock_news_url": "https://www.marketsmojo.com/news/eris-lifesciences-1002771"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment",
      "datetime": "22-Sep-2026",
      "details": "As attached",
      "source": "BSE"
    },
    {
      "caption": "Appointment Of Mr. Akhil Awasthi As An Additional Director (Non-Executive Independent) Of The Company",
      "datetime": "21-Sep-2026",
      "details": "as attached",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
      "datetime": "11-Sep-2026",
      "details": "As Attached",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "ERIS Lifesciences Ltd has declared <strong>721%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

ERIS Lifesciences Ltd is Rated Sell

2026-09-19 10:10:47

ERIS Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 26 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 September 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

ERIS Lifesciences Ltd is Rated Sell by MarketsMOJO

2026-09-08 10:11:17

ERIS Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 26 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 September 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

ERIS Lifesciences Declines 0.63%: Technical Weakness and Growth Concerns Weigh

2026-08-29 13:02:30

Key Events This Week

Aug 24: Stock edges up slightly to ₹1,326.20 despite Sensex decline

Aug 25: Stock falls 1.26% amid Sensex gains

Aug 27: Downgrade to Sell rating announced with bearish technical signals

Aug 28: Stock recovers modestly to close at ₹1,317.10

Week Open

Rs.1,325.50

Week Close

Rs....

Read full news article

ERIS Lifesciences Downgraded to Sell Amid Technical Weakness and Growth Concerns

2026-08-27 08:21:53

ERIS Lifesciences Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 26 Aug 2026, reflecting a deterioration in its technical outlook and continued underperformance relative to the broader market. Despite some positive financial metrics, the stock’s bearish technical signals and weak price returns over the past year have prompted a reassessment of its investment appeal.

Read full news article

ERIS Lifesciences Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-08-27 08:04:09

ERIS Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, prompting a downgrade from Hold to Sell by MarketsMOJO as of 26 August 2026. The stock’s price action and technical indicators reveal a growing bearish sentiment, reflecting challenges in sustaining upward momentum amid broader market pressures.

Read full news article

ERIS Lifesciences Ltd is Rated Hold by MarketsMOJO

2026-08-16 10:10:41

ERIS Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 August 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

ERIS Lifesciences Ltd is Rated Hold by MarketsMOJO

2026-08-05 10:11:29

ERIS Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

ERIS Lifesciences Declines 3.30% Amid Valuation Reset and Margin Pressures

2026-08-01 13:05:35

Key Events This Week

27 Jul: Stock opens at Rs.1,399.95, marginal gain despite Sensex rally

29 Jul: Q1 FY27 results announced with strong sales growth but margin pressure

31 Jul: Valuation shifts to fair; stock closes lower at Rs.1,352.75

31 Jul: Week closes with a 3.30% decline in stock price versus Sensex +2.39%

Week Open

Rs.1,398.90

Read full news article

ERIS Lifesciences Ltd Valuation Shifts to Fair Amidst Sector Volatility

2026-07-31 08:00:52

ERIS Lifesciences Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling a more attractive entry point for investors. Despite a recent 3.62% decline in its share price to ₹1,375.60, the pharmaceutical and biotechnology company’s improved price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to peers and historical averages suggest a recalibration of market expectations amid broader sector dynamics.

Read full news article

View All News